High-dose intravenous estrogen therapy in advanced prostatic carcinoma: Use of serum prostate-specific antigen to monitor response
- 30 September 1989
- journal article
- Published by Elsevier BV in Urology
- Vol. 34 (3), 134-138
- https://doi.org/10.1016/0090-4295(89)90248-3
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- CLINICAL TRIAL OF MASSIVE STILBŒSTROL DIPHOSPHATE THERAPY IN ADVANCED CARCINOMA OF THE PROSTATEBritish Journal of Urology, 2008
- Effect of Stilboestrol and Testosterone on the Incorporation of75Selenomethionine by Prostatic Carcinoma CellsBritish Journal of Urology, 1988
- Tumour Markers in Prostatic Carcinoma. A Comparison of Prostate‐specific Antigen with Acid PhosphataseBritish Journal of Urology, 1987
- An Evaluation of the Immunochemical Measurement of Prostatic Acid Phosphatase and Prostatic Specific Antigen in Carcinoma of the ProstateEuropean Urology, 1986
- Bioavailability, Distribution and Pharmacokinetics of Diethylstilbestrol Produced from StilphostrolJournal of Urology, 1982
- Management of adenocarcinoma of prostate with diethylstilbestrol diphosphate and cyclophosphamideUrology, 1975
- Paraplegia and paraparesis due to prostatic cancer: Use of intravenous diethylstilbestrol diphosphateUrology, 1974
- THE PLACE OF HONVAN (DIETHYLSTILB(ESTROL DIPHOSPHATE) IN THE TREATMENT OF PROSTATIC CANCERBritish Journal of Urology, 1965
- STILBCESTROL DIPHOSPHATE (HONVAN) IN THE TREATMENT OF ACUTE URINARY RETENTION DUE TO PROSTATIC CARCINOMA1British Journal of Urology, 1965
- Prostatic Carcinoma: Treatment of Advanced Cases with Intravenous Diethylstilbestrol DiphosphateJournal of Urology, 1955